An asset manager has secured more than $210 million to refinance a nine-building, 58-acre campus in Plainsboro that serves as Novo Nordisk’s North American headquarters.
A global medical technology maker has proposed relocating within Plainsboro to a nearly 167,000-square-foot building once occupied by Novo Nordisk, thanks in part to a 10-year, $17.8 million tax credit approved last week by state officials.
The state’s office market took a step back in the fourth quarter of 2016, according to new industry research, as leasing activity slowed and several large blocks of space hit the market.